CHEK
- Check-Cap Ltd.
()
Overview
Company Summary
Check-Cap Ltd. is a medical technology company that specializes in the development of capsule-based, ingestible imaging devices. These devices are designed to help healthcare professionals in the early detection of colorectal cancer.
The company's flagship product is the C-Scan� system, which consists of an ingestible, ultra-low dose X-ray capsule, a positioning system, and a data receiver. When a patient swallows the capsule, it travels through the digestive system, capturing images of the colon as it passes through. The capsule is equipped with sensors that detect changes in electrical conductivity caused by abnormal growths, such as polyps or tumors.
The images and data collected by the capsule are wirelessly transmitted to the receiver, which is worn by the patient and records the information. This data is then analyzed by healthcare professionals using Check-Cap's proprietary algorithms, aiding in the detection and localization of potential abnormalities.
Check-Cap's technology offers several advantages over traditional colonoscopy procedures, such as being less invasive, more comfortable for the patient, and eliminating the need for bowel preparation. It also has the potential to increase patient compliance with screening, ultimately improving early detection rates and reducing the burden of colorectal cancer.
In addition to the C-Scan� system, Check-Cap is engaged in ongoing research and development to expand its product portfolio and explore potential applications of its technology in other areas, such as diagnosing other gastrointestinal conditions or providing targeted drug delivery.
Overall, Check-Cap Ltd. is focused on revolutionizing colorectal cancer screening by providing a non-invasive, patient-friendly alternative to traditional methods, ultimately aiming to improve patient outcomes and save lives.